Human iPSC Artificial Skin

About Eureka Biotechnology

Eureka Biotech, founded in 2015 and headquartered in Philadelphia, Pennsylvania, is a private, pre-revenue biotech firm specializing in induced pluripotent stem cell (iPSC) and organoid platforms. Its core activities include developing disease-specific iPSCs, brain and heart organoids for drug screening, and artificial skin models, with a secondary initiative in cultured meat production. The company operates as a subsidiary of the Eureka International Group and is strategically positioned near major academic institutions to facilitate research and collaboration.

Therapeutic Areas